910634-41-2Relevant articles and documents
AGENT FOR TREATMENT OF HEMATOPOIETIC TUMOR
-
, (2010/11/29)
A therapeutic and/or prophylactic agent for a hematopoietic tumor, which comprises a thiadiazoline derivative represented by the general formula (I), or a pharmaceutically acceptable salt thereof: [wherein, n represents an integer of 1 to 3, R1
THERAPEUTIC AGENT FOR RESTENOSIS
-
, (2010/11/25)
A therapeutic and/or prophylactic agent for restenosis comprising a thiadiazoline derivative represented by the general formula (O) or a pharmaceutically acceptable salt thereof: wherein n represents an integer of 1 to 3; R0 represents an aryl,
THIADIAZOLINE DERIVATIVE
-
Page 72, (2010/02/08)
(wherein R1 and R4 are the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkynyl, substituted or unsubstituted lower alkenyl, or the like; R5 represents a substituted or unsubstituted heterocyclic group, substituted or unsubstituted aryl, or the like; R2 represents -C(-W)R6 or the like; R3 represents a hydrogen atom, -C(=WA)R6A, or the like) Antitumor agents which comprises a thiadiazoline derivative represented by the aforementioned general formula (I) or a pharmacologically acceptable salt thereof as an active ingredient are provided.